All visceral leishmaniasis articles
-
NewsPromising patient-friendly oral drug against visceral leishmaniasis enters Phase II clinical trial in Ethiopia
The new molecule has the potential to revolutionize treatment for the deeply neglected and hard-to-treat disease, as the Eastern Africa region charts the way to its elimination.
-
NewsNanoparticles containing lupeol treat visceral leishmaniasis with scant side effects
In animal tests conducted at São Paulo State University (UNESP), the strategy reduced spleen and liver parasite numbers by 99.9%.
-
NewsTest detects co-infection by novel parasite in severe cases of visceral leishmaniasis
The test developed by Brazilian researchers accurately identifies the causative agent in less than two hours, so that treatment can be properly targeted.
-
NewsGenetic fingerprint suggests cutaneous leishmaniasis may be gaining foothold in US
Analysis reveals DNA evidence of a US-acquired strain of cutaneous leishmaniasis - the prospect of a growing threat comes amidst concerns that domestic sand flies could acquire a deadly form of the disease via dog imports.
-
NewsLeishmania’s secret weapon is ability to infect non-immune cells
The parasites that cause visceral leishmaniasis appear to have a secret weapon, new research suggests - they can infect non-immune cells and persist in those uncommon environments.
-
NewsCo-infection by novel species of parasite found in visceral leishmaniasis patient
Genome sequencing of clinical samples from a child has revealed the simultaneous presence of the protozoan Leishmania infantum and an as-yet unnamed parasite that was identified earlier in a fatal case of visceral leishmaniasis.
